论文信息 - Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial - 字舞流文

Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial

N. Horita | Keisuke Watanabe | T. Kaneko | Masaki Yamamoto | Hiroki Watanabe | K. Nakashima | R. Ushio | N. Kobayashi | M. Kudo | S. Kubo | C. Kamimaki | S. Katakura | R. Nagasawa | H. Piao | Katsushi Tanaka | Hisashi Hashimoto | A. Aoki | N. Hirama | Hao Chen | Yu Hara | Saki Manabe | Shuhei Teranishi